Amy E. Lodolce

458 total citations
11 papers, 344 citations indexed

About

Amy E. Lodolce is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Economics and Econometrics. According to data from OpenAlex, Amy E. Lodolce has authored 11 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 2 papers in Geriatrics and Gerontology and 2 papers in Economics and Econometrics. Recurrent topics in Amy E. Lodolce's work include Pharmaceutical Economics and Policy (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Pharmaceutical studies and practices (2 papers). Amy E. Lodolce is often cited by papers focused on Pharmaceutical Economics and Policy (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Pharmaceutical studies and practices (2 papers). Amy E. Lodolce collaborates with scholars based in United States. Amy E. Lodolce's co-authors include Nancy L. Shapiro, Peter West, A. Simon Pickard, Daniel R. Touchette, Surrey M. Walton, William Galanter, Michael J. Koronkowski, Bruce L. Lambert, Gordon D. Schiff and Michael Gabay and has published in prestigious journals such as PLoS Medicine, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.

In The Last Decade

Amy E. Lodolce

11 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Lodolce United States 8 76 63 53 43 42 11 344
Syed Wasif Gillani United Arab Emirates 14 26 0.3× 109 1.7× 38 0.7× 61 1.4× 28 0.7× 97 693
Marianne F. Ivey United States 14 151 2.0× 73 1.2× 109 2.1× 15 0.3× 100 2.4× 58 567
Khadijeh Makhdoomi Iran 13 19 0.3× 81 1.3× 30 0.6× 79 1.8× 11 0.3× 53 457
Mariana Martins Gonzaga do Nascimento Brazil 12 40 0.5× 46 0.7× 49 0.9× 23 0.5× 25 0.6× 86 564
Susan Kecskes United States 8 136 1.8× 82 1.3× 79 1.5× 4 0.1× 32 0.8× 18 320
Yet Hoi Hong Malaysia 13 83 1.1× 21 0.3× 65 1.2× 10 0.2× 13 0.3× 22 477
Thomas J. Best United States 11 96 1.3× 60 1.0× 13 0.2× 25 0.6× 227 5.4× 21 656
Barbara Claus Belgium 10 116 1.5× 77 1.2× 62 1.2× 11 0.3× 3 0.1× 25 495
Michael Tierney Canada 11 50 0.7× 34 0.5× 47 0.9× 9 0.2× 24 0.6× 22 535
Darryl S. Rich United States 10 100 1.3× 34 0.5× 144 2.7× 20 0.5× 16 0.4× 36 464

Countries citing papers authored by Amy E. Lodolce

Since Specialization
Citations

This map shows the geographic impact of Amy E. Lodolce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Lodolce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Lodolce more than expected).

Fields of papers citing papers by Amy E. Lodolce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Lodolce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Lodolce. The network helps show where Amy E. Lodolce may publish in the future.

Co-authorship network of co-authors of Amy E. Lodolce

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Lodolce. A scholar is included among the top collaborators of Amy E. Lodolce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Lodolce. Amy E. Lodolce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Schiff, Gordon D., William Galanter, Michael J. Koronkowski, et al.. (2012). A Prescription for Improving Drug Formulary Decision Making. PLoS Medicine. 9(5). e1001220–e1001220. 63 indexed citations
2.
Lodolce, Amy E.. (2012). Shortened Interval between Tetanus Vaccines. Annals of Pharmacotherapy. 46(6). 884–888. 4 indexed citations
3.
Ipema, Heather J., et al.. (2011). Medication Repurposing: New Uses for Old Drugs. Journal of Pharmacy Technology. 27(3). 132–140. 5 indexed citations
4.
Lodolce, Amy E., et al.. (2011). Efficacy of Agents to Prevent and Treat Enteral Feeding Tube Clogs. Annals of Pharmacotherapy. 45(5). 676–680. 34 indexed citations
5.
Gabay, Michael, et al.. (2010). Safety Concerns Involving Transdermal Patches and Magnetic Resonance Imaging (MRI). Hospital Pharmacy. 45(10). 771–778. 10 indexed citations
6.
Ipema, Heather J., et al.. (2009). New Drug Approvals: Romiplostim Management of Immune Thrombocytopenic Purpura. Annals of Pharmacotherapy. 43(5). 914–919. 8 indexed citations
7.
West, Peter, et al.. (2007). Bisphosphonate-Induced Osteonecrosis of the Jaw. Annals of Pharmacotherapy. 41(2). 276–284. 47 indexed citations
8.
Lodolce, Amy E., et al.. (2006). Interaction Between Warfarin and Cranberry Juice. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(9). 1314–1319. 43 indexed citations
9.
Lodolce, Amy E., et al.. (2005). Use of failure mode and effects analysis in improving the safety of i.v. drug administration. American Journal of Health-System Pharmacy. 62(9). 917–920. 103 indexed citations
10.
Lodolce, Amy E., et al.. (2004). High- versus Low-Dose Oxytocin for Augmentation or Induction of Labor. Annals of Pharmacotherapy. 39(1). 95–101. 22 indexed citations
11.
West, Peter, et al.. (2001). Telephone service for providing consumers with information on herbal supplements. American Journal of Health-System Pharmacy. 58(19). 1842–1846. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026